Screener
Immunome IMNM Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $217.71M+51.3% | $582.69M+126% | $653.48M+356% | $272.64M+75.3% | $143.88M-13.0% | ||
| $302.29M+143% | —— | $0-100% | $0-100% | $124.16M+9.9% | ||
| $538.45M+94.1% | $594.31M+83.9% | $660.78M+199% | $279.92M+14.7% | $277.43M-2.4% | ||
| $17.36M+57.5% | $17.08M+55.9% | $14.64M+44.7% | $11.56M+61.2% | $11.03M+80.9% | ||
| $565.38M+90.8% | $619.79M+80.9% | $683.19M+184% | $299.38M+16.5% | $296.29M0.0% | ||
| $6M+28.7% | $5.53M-39.4% | $3.34M-76.5% | $6.15M+74.7% | $4.66M-33.9% | ||
| —— | —— | $0-100% | $0-100% | $0-100% | ||
| $35.71M+56.1% | $27.41M-11.0% | $44.99M-17.2% | $31.45M-20.4% | $22.88M-42.7% | ||
| $40.3M+49.2% | $31.11M-12.5% | $48.85M-17.3% | $35.46M-15.6% | $27.02M-36.2% | ||
| $11K+22.2% | $11K+22.2% | $11K+83.3% | $9K+50.0% | $9K+50.0% | ||
| -$855.13M-42.3% | -$782M-40.3% | -$728.16M-41.2% | -$658.26M-51.1% | -$600.81M-54.7% | ||
| $525.08M+95.0% | $588.69M+91.7% | $634.34M+250% | $263.92M+22.8% | $269.27M+6.1% | ||
| $565.38M+90.8% | $619.79M+80.9% | $683.19M+184% | $299.38M+16.5% | $296.29M0.0% |
FAQ
- What are Immunome's total assets?
- Immunome (IMNM) holds $565.4M in total assets, up 90.8% year over year.
- How much debt does Immunome have?
- Immunome carries $4.7M in total debt against $525.1M of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Immunome have?
- Immunome holds $217.7M in cash and equivalents.
- Can Immunome cover its short-term obligations?
- Its current ratio is 15.08 — current assets exceed current liabilities.
- Where does Immunome's balance sheet data come from?
- Every line is extracted from Immunome's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.